Strategies for Business Capacity Expansion in Jordanian Pharmaceutical Companies

Shareholder investments declined in Jordanian pharmaceutical business expansion between 2007 and 2014, which included a reduction in the supply of essential medicines in the Middle East and North Africa (MENA). The purpose of this qualitative multiple case study was to explore effective applications...

Full description

Bibliographic Details
Main Author: Al-Jallad, Tariq Ahmad
Format: Others
Language:en
Published: ScholarWorks 2017
Subjects:
Online Access:https://scholarworks.waldenu.edu/dissertations/3424
https://scholarworks.waldenu.edu/cgi/viewcontent.cgi?article=4527&context=dissertations
id ndltd-waldenu.edu-oai-scholarworks.waldenu.edu-dissertations-4527
record_format oai_dc
spelling ndltd-waldenu.edu-oai-scholarworks.waldenu.edu-dissertations-45272019-10-30T01:17:40Z Strategies for Business Capacity Expansion in Jordanian Pharmaceutical Companies Al-Jallad, Tariq Ahmad Shareholder investments declined in Jordanian pharmaceutical business expansion between 2007 and 2014, which included a reduction in the supply of essential medicines in the Middle East and North Africa (MENA). The purpose of this qualitative multiple case study was to explore effective applications of expansion strategies to satisfy demand in the MENA markets among Jordanian generic pharmaceutical companies' managers. The conceptual framework for this study was based on the transformational leadership theory and stakeholders' theory. The purposive sample consisted of 4 chief executive officers and 8 managers from Jordanian pharmaceutical companies who practiced the expansion strategy in the MENA for more than 10 years. The data were triangulated from semi structured interviews and cash flow financial statements. Interpretation summaries of the participants' answers were applied for the member-checking process to bolster the trustworthiness of interpretations. Four themes emerged from the analysis process: leaders' adaptability to change, financial capacity and stability, stakeholders' business awareness, and managers' engagements and knowledge. The findings may provide the generic pharmaceutical business leaders and managers with increased growth capabilities for catalyzing beneficial positive capacity expansion strategies. The subsequent expansion could provide adequate, affordable, and accessible medications for effecting social changes by fighting disease in remote and low-income MENA communities. 2017-01-01T08:00:00Z text application/pdf https://scholarworks.waldenu.edu/dissertations/3424 https://scholarworks.waldenu.edu/cgi/viewcontent.cgi?article=4527&context=dissertations Walden Dissertations and Doctoral Studies en ScholarWorks Expansion Growth Jordan MENA Pharmaceutical Strategies Business Other Education
collection NDLTD
language en
format Others
sources NDLTD
topic Expansion
Growth
Jordan
MENA
Pharmaceutical
Strategies
Business
Other Education
spellingShingle Expansion
Growth
Jordan
MENA
Pharmaceutical
Strategies
Business
Other Education
Al-Jallad, Tariq Ahmad
Strategies for Business Capacity Expansion in Jordanian Pharmaceutical Companies
description Shareholder investments declined in Jordanian pharmaceutical business expansion between 2007 and 2014, which included a reduction in the supply of essential medicines in the Middle East and North Africa (MENA). The purpose of this qualitative multiple case study was to explore effective applications of expansion strategies to satisfy demand in the MENA markets among Jordanian generic pharmaceutical companies' managers. The conceptual framework for this study was based on the transformational leadership theory and stakeholders' theory. The purposive sample consisted of 4 chief executive officers and 8 managers from Jordanian pharmaceutical companies who practiced the expansion strategy in the MENA for more than 10 years. The data were triangulated from semi structured interviews and cash flow financial statements. Interpretation summaries of the participants' answers were applied for the member-checking process to bolster the trustworthiness of interpretations. Four themes emerged from the analysis process: leaders' adaptability to change, financial capacity and stability, stakeholders' business awareness, and managers' engagements and knowledge. The findings may provide the generic pharmaceutical business leaders and managers with increased growth capabilities for catalyzing beneficial positive capacity expansion strategies. The subsequent expansion could provide adequate, affordable, and accessible medications for effecting social changes by fighting disease in remote and low-income MENA communities.
author Al-Jallad, Tariq Ahmad
author_facet Al-Jallad, Tariq Ahmad
author_sort Al-Jallad, Tariq Ahmad
title Strategies for Business Capacity Expansion in Jordanian Pharmaceutical Companies
title_short Strategies for Business Capacity Expansion in Jordanian Pharmaceutical Companies
title_full Strategies for Business Capacity Expansion in Jordanian Pharmaceutical Companies
title_fullStr Strategies for Business Capacity Expansion in Jordanian Pharmaceutical Companies
title_full_unstemmed Strategies for Business Capacity Expansion in Jordanian Pharmaceutical Companies
title_sort strategies for business capacity expansion in jordanian pharmaceutical companies
publisher ScholarWorks
publishDate 2017
url https://scholarworks.waldenu.edu/dissertations/3424
https://scholarworks.waldenu.edu/cgi/viewcontent.cgi?article=4527&context=dissertations
work_keys_str_mv AT aljalladtariqahmad strategiesforbusinesscapacityexpansioninjordanianpharmaceuticalcompanies
_version_ 1719281755832188928